Navigating the Legal Ramifications of Undisclosed Real Party of Interest Relationships

In a recent episode of “The Briefing”, legal experts Scott Hervey and Eric Caligiuri discussed the implications of failing to disclose relationships with a real party of interest – a topic of significance that merits attention from legal professionals globally. Hervey and Caligiuri, hailing from Weintraub Tobin, broke down the substantial consequences that can arise…

Read More

Pharmaceutical Giants Tackle Patent Law Obviousness in Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Case

In a recent federal case, Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc., the issues of subject matter eligibility and obviousness were once again brought to the fore. The case follows on from landmark Supreme Court decisions including Mayo, Myriad, Alice, and most notably, KSR Int’l Co. v. Teleflex Inc. (2007), in which the Court first…

Read More

Supreme Court Ruling Streamlines Patent Challenges, Bolsters Competition in Pharmaceutical Industry

On May 18, 2023, the Supreme Court upheld a decision on streamlining patent challenges by rivals against drug makers. This outcome was brought into effect through the ruling in the case, Amgen Inc. v. Sanofi, as it confirms the Federal Circuit’s (CAFC) decision on enablement. This significant CAFC decision makes it more challenging for pharmaceutical…

Read More

Cannabis Industry Adapts to Unique Intellectual Property Challenges with Employment Agreements

The cannabis industry, already rife with its own set of unique legal hurdles, is now tackling the challenge of protecting intellectual property—a particularly vulnerable area for any young, rapidly growing sector. Any successful business strategy needs a mandatory need for comprehensive employment agreements as part of its operational bedrock. As noted in this comprehensive, rigorous…

Read More

Understanding Hatch-Waxman and BPCIA: Proficiency Series for Legal and Life Sciences Professionals

A webinar series, titled “3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA,” is slated to hold from October 10th through 26th, starting daily at 1:00 pm EST. This digital event comes with an especial interest for legal professionals and business executives involved in the biopharmaceutical industry as it aims to provide…

Read More

Intellectual Property Rights Dilemma: Zotz’s International Expansion Hindered by Patent Issues

Recent events have spotlighted a growing concern in the international business and legal sectors related to intellectual property rights and patent filing procedures. A specific highly-publicized case revolves around a company named Zotz, which designs and manufactures toys for children. As described in a recent article on JD Supra, Zotz decided to expand its operations…

Read More